Travere Therapeutics, Inc. (TVTX) CEO Dr. Eric Dube on Q2 2021 Results – Earnings Call Transcript

Travere Therapeutics, Inc. (NASDAQ:TVTX) Q2 2021 Results Conference Call July 29, 2021 4:30 PM ET
Company Participants
Chris Cline – SVP, IR & Corporate Communications
Dr. Eric Dube – CEO
Dr. Noah Rosenberg – Chief Medical Officer
Peter Heerma – Chief Commercial…

Click here to view the original article.